MedPath
NMPA Approval

Zuberitamab Injection

国药准字S20230028

May 12, 2023

Drug Information

泽贝妥单抗注射液

安瑞昔

注射剂

100mg(10ml)/瓶

生物制品

May 12, 2023

Company Information

Applicant Company

浙江省台州市椒江区疏港大道1号

Manufacturing Company

浙江省杭州市富阳区胥口镇海正路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

泽贝妥单抗注射液 - NMPA 批准文号 | MedPath